Yimeng Zou

Development and evaluation of a recombinant VP2 neutralizing epitope antigen vaccine candidate for infectious bursal disease virus.

M. Jiang, Xiaochen Guo, G. Ren, 2021, Transboundary and emerging diseases.

Fibroblast growth factor 21 attenuates the progression of hyperuricemic nephropathy through inhibiting inflammation, fibrosis and oxidative stress

G. Ren, Y. Opoku, Dan Wang, 2022, Basic & clinical pharmacology & toxicology.